Embodiments of the present disclosure provide a biofield apparatus. The apparatus includes a first vial and a second vial configured to hold fluid for storing biofield information associated with a subject. The apparatus includes an input plate and an output plate. The input plate and the output plate include an input plate vial well and an output plate vial well, respectively. The apparatus includes a control unit configured to provide a first signal to the input plate for capturing the biofield information from the subject. The control unit encodes and transmits the biofield information captured from the subject, to the fluid within the first vial. Further, the control unit amplifies the biofield information within the first vial based on a target amplification level. The control unit transmits the biofield information from the fluid within the second vial to the subject for enhancing the biofield information and properties of the subject.

A photobiomodulation (PBM) device including eyewear (e.g., incorporating prescription or non-prescription lenses) that is worn throughout the day is provided. The PBM device provides longer-term light delivery throughout the day and may capture patient compliance, provide real-time dose adjustments, and allow for HIPAA-compliant communication with the prescribing clinician. The PBM device provides a wearable, open eye device format designed for increased compliance, lower cost, and greater convenience.

A method, system and computer-readable medium of utilizing artificial lighting regulate a circadian clock of a human. By utilizing light emitting diodes (LEDs) that emit wavelengths associated with human opsin absorption spectra, a device may stimulate opsins in the human. For example, the device may replicate normal sunlight (e.g., based on season or time of day) by emitting light that changes in rhythmic intensity or spectral modulation.

A device for enhancement of visual appearance including a first applicator to be coupled to a first area of a body region, with a first magnetic field generating device and a first radiofrequency electrode, a second applicator to be coupled to a second area of the body region, with a second magnetic field generating device. The device further includes a first energy storage device, a second energy storage device, and a first switching device to discharge energy from the first energy storage device to the first magnetic field generating to generate a first time-varying magnetic field to cause muscle contraction, and a second switching to discharge energy from the second energy storage device to the second magnetic field generating device to generate a second time-varying magnetic field. The first radiofrequency electrode may provide first radiofrequency waves causing heating of tissue within the first area of the body region.

An ingestible gastrointestinal phototherapy device has a spherocylindrical body of non-digestible material having a cylindrical midsection and transparent light portals at ends thereof. The cylindrical midsection has control circuitry and a power source therein and each light portal is transparent and comprises an array of bioactive light source elements therein emitting bioactive light therefrom and being operably coupled to the control circuitry and power source.

Wearable apparatus for the treatment of mastitis, the apparatus comprising a mammary gland wearable comprising an array of light source elements thereon emitting electromagnetic radiation having a wavelength in the range of 380-1050 nm, a power supply coupled to the array of light source elements, the wearable configured to be worn against a mammary gland in use wherein the array of light source elements emit the radiation which penetrates epidermis of the mammary gland for the treatment of mastitis.

A computer system for blue-light therapy comprising one or more processors, one or more computer-readable memories, and one or more computer-readable storage devices, and program instructions stored on at least one of the one or more storage devices for execution by at least one of the one or more processors via at least one of the one or more memories, the stored program instructions including determining a need for blue-light therapy, and providing a blue-light stimulus to a user, wherein the blue-light stimulus comprises a visible range of 380 to 500 nm, and wherein, in response to the blue-light stimulus, a circadian rhythm of the user is shifted to a second rhythm, the second rhythm different than the circadian rhythm prior to the administration of the blue-light stimulus.

A wearable for providing light therapy to a wearer includes at least one fabric panel having an inner surface that when the wearable is worn is configured to face a wearer's skin and at least one side-emitting optical fiber affixed to the inner surface. The side-emitting optical fiber is optically connectable with an optical fiber light source and configured to project light having a therapeutic wavelength toward a wearer of the wearable. When affixed to the fabric panel, the side-emitting optical fiber can have a length in meters based on the optical power launched into the side-emitting optical fiber and the average attenuation of the side-emitting optical fiber.

A photobiomodulation system includes a) a control module having electronic subassembly disposed in a housing, a connector coupled to the housing and defining a connector lumen, and at least one light source to produce light in response to signals from the electronic subassembly; b) a lead coupled or coupleable to the control module and having a lead body defining a lead lumen and at least one opening along a distal portion of the lead, light emitters arranged along the distal portion of the lead, and optical fibers extending along the lead body and coupled to the light emitters; and c) a catheter assembly having a tube coupleable to a catheter pump, and a distal connector attached to the end of the tube and coupled or coupleable to the connector of the control module.

A light therapy apparatus includes a first source voltage line including a first sub-source voltage line and a second sub-source voltage line, which are electrically insulated from each other, a first light emitting element connected to the first sub-source voltage line, where the first light emitting element includes a first intermediate layer, and a second light emitting element connected to the second sub-source voltage line, where the second light emitting element includes a second intermediate layer. The first intermediate layer has a first thickness, and the second intermediate layer has a second thickness greater than the first thickness.